Tag Archives: Market Access
Commercial Eyes Recruiting: Research Associate, Market Access
Apply your research and healthcare skills to support our growing market access team. The role… This role is part of the Market Access team and will work closely with consultants to deliver expert consulting services to clients in the … Continue reading
PHARMAC issues a call for funding applications for medicines for rare disorders
Applications will be accepted until 5pm on the 5th of August 2019 and will be considered by the Rare Disorders Subcommittee at their meeting scheduled for the 24th of September 2019. Eligibility criteria: The medicine must have been approved … Continue reading
PBAC Meeting Outcomes – July 2018
The July 2018 PBAC Meeting Outcomes were published on 17th August 2018. With 64 outcomes in total, the Commercial Eyes Market Access team provides an overview of PBAC decision making, including additional analysis conducted on biosimilar and oncology submissions. … Continue reading
PBAC Special Meeting – August 2018
The August 2018 PBAC special meeting is scheduled for 17 August 2018 to consider options for listing PD-1 and PD-L1 checkpoint inhibitors for the treatment of multiple tumours (pan-tumour indications) on the PBS. Here, the Commercial Eyes Market Access team … Continue reading
The long road to PBS listing for Orkambi
Orkambi (lumacaftor and ivacaftor), a treatment for cystic fibrosis (CF), will go before the PBAC for a fourth time at the upcoming July 2018 PBAC meeting. So far, the road to reimbursement has been filled with multiple rejections, a strong … Continue reading
PBAC Meeting Agenda – July 2018
The July 2018 PBAC Meeting is scheduled from 4 to 6 Jul 2018. Here, the Commercial Eyes Market Access team provides an overview of the meeting agenda, including submissions relating to biosimilars lodged for this meeting. The Commercial … Continue reading
PBAC Meeting Outcomes – March 2018
The March 2018 PBAC Meeting Outcomes were published on 20th April 2018. With 71 outcomes in total, the Commercial Eyes Market Access team provides an overview of PBAC decision making, including an additional analysis conducted on oncology submissions which have … Continue reading
PBAC outcomes: a snapshot of 2017
The Commercial Eyes Market Access Team can help you navigate Australia and New Zealand’s sophisticated and mature systems of Health Technology Assessment. Contact us on (03) 9251 0777 to learn more about our PBAC Outcomes Database and let us … Continue reading
Commercial Eyes Recruiting: Senior Market Access Consultant
Commercial Eyes has a great opportunity for a Senior Market Access consultant to join our dynamic Market Access team. Reporting to the Health Economics and Market Access Manager, this senior consulting role offers the successful candidate the opportunity to gain … Continue reading
Contemporary Economic Modelling – State of the Art
The Albert Einstein adage, “Everything should be made as simple as possible, but not simpler.” was the overarching principal that economic modellers should adhere to, communicated in the quarterly workshop session “Contemporary Economic Modelling”, attended by members of Commercial Eyes’ … Continue reading
